Active Ingredient(s): Floxuridine
FDA Approved: * December 18, 1970
Pharm Company: * MAYNE PHARMA USA
Category: Cancer

Floxuridine (also 5-fluorodeoxyuridine) is an oncology drug that belongs to the class known as antimetabolites. Specifically, floxuridine is a pyrimidine analog, classified as a deoxyuridine.[1] The drug is usually administered via an artery, and most often used in the treatment of colorectal cancer. The quality of life and survival rates of individuals that receive continuous hepatic artery infusion of floxuridine for colorectal cancer metastases is significantly higher than ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.